Allstate reports Q2 catastrophe losses of $1.72B

scanx
Reviewed by
Riya DScanX News Team
Key Highlights

Allstate Corporation reported estimated catastrophe losses of $563 million for June 2026, contributing to a total of $1.72 billion for the second quarter. The after-tax impact for June was $445 million, while the second-quarter after-tax losses amounted to $1.36 billion.

powered bylight_fuzz_icon
45751850

*this image is generated using AI for illustrative purposes only.

The Allstate Corporation reported estimated catastrophe losses of $563 million for June 2026, contributing to a total of $1.72 billion for the second quarter. The after-tax impact for June was $445 million, while the second-quarter after-tax losses amounted to $1.36 billion. These figures reflect the financial strain of severe weather events and natural disasters during the period.

Catastrophe Loss Breakdown

The insurer disclosed that pre-tax catastrophe losses for June alone amounted to $563 million. These losses contributed to the aggregate second-quarter figure, highlighting the frequency and severity of weather-related claims during the three-month period.

Period Catastrophe Losses (Pre-tax)
June $563 million
Q2 Total $1.72 billion

The data was submitted via a regulatory filing, providing transparency regarding the financial impact of recent catastrophic events on the company's underwriting results.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

How will these catastrophe losses impact Allstate's pricing strategy and premium rates for the upcoming policy renewals?

Will Allstate need to raise additional capital or re-evaluate its reinsurance coverage to mitigate future severe weather risks?

How might these losses affect Allstate's share buyback program and dividend policy for the remainder of the fiscal year?

like20
dislike

UBS downgrades Allstate to Neutral, raises target to $261

scanx
Reviewed by
Radhika SScanX News Team
Key Highlights

UBS analyst Brian Meredith downgraded Allstate from Buy to Neutral, raising the price target to $261 from $255. This follows adjustments from other analysts, including HSBC's downgrade to Hold with a $264 target, Barclays' raised target to $213, and Keefe, Bruyette & Woods' increase to $255.

powered bylight_fuzz_icon
44881939

*this image is generated using AI for illustrative purposes only.

Analysts have revised their outlooks on Allstate, with UBS downgrading the stock while several other firms adjusted price targets. UBS analyst Brian Meredith downgraded Allstate from Buy to Neutral and raised the price target from $255 to $261. The changes reflect shifting perspectives on the insurance provider's stock performance and valuation.

HSBC analyst Vikram Gandhi previously downgraded Allstate from Buy to Hold while raising the price target to $264 from $244. Barclays analyst Alex Scott maintained an Underweight rating and raised the price target to $213 from $203. Keefe, Bruyette & Woods analyst Meyer Shields maintained a Market Perform rating and raised the price target from $242 to $255. Cantor Fitzgerald analyst Ryan Tunis maintained a Neutral rating and raised the price target from $236 to $242.

The adjustments signal varied views on the company's future trajectory. UBS's downgrade accompanies a higher target, suggesting a more cautious stance on near-term momentum despite increased valuation expectations. HSBC's move similarly paired a rating cut with a target increase. Barclays and Keefe, Bruyette & Woods retained their bearish and neutral ratings respectively while acknowledging potential upside through higher targets.

Analyst Rating Previous Target New Target
UBS (Brian Meredith) Neutral $255 $261
HSBC (Vikram Gandhi) Hold $244 $264
Barclays (Alex Scott) Underweight $203 $213
Keefe, Bruyette & Woods (Meyer Shields) Market Perform $242 $255
Cantor Fitzgerald (Ryan Tunis) Neutral $236 $242
Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What specific factors are driving the divergence between UBS's downgrade and the raised price targets across multiple firms?

How might Allstate's near-term performance be impacted by the cautious stance adopted by analysts despite higher valuation expectations?

What broader market conditions could be influencing the varied outlooks from Barclays, HSBC, and Keefe, Bruyette & Woods?

like18
dislike

More News on Allstate Corp